Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Showcases New Product Innovations and Best Practices to Optimize Stem Cell Discoveries at ISSCR 2014

Published: Monday, June 23, 2014
Last Updated: Monday, June 23, 2014
Bookmark and Share
Enabling engineering, expansion, differentiation, characterization, cryopreservation and ultra-cold chain to drive drug discovery applications.

The latest advances in innovative technologies designed to streamline the entire stem cell research workflow – from pluripotent cell engineering, culturing, differentiation and characterization to cryopreservation and storage – will be showcased this week during the 12th annual International Society for Stem Cell Research (ISSCR) meeting (Thermo Scientific booth #628, Life Technologies booth #829). 

Thermo Fisher Scientific will host a series of customer and thought leader presentations on topics ranging from the use of Sendai virus reprogramming technology for rapid development of human induced pluripotent stem cells (iPSC) for drug development applications, to industrializing pluripotent stem cells and novel platforms for culturing cells in suspension. The speakers will share new innovations being applied in labs at Harvard University, Cedar-Sinai Medical Center and Saitama Medical University. 

“Access to leading-edge tools that are designed to seamlessly work in combination with each other is critical for our customers to drive new discoveries,” said Chris Armstrong, Ph.D., vice president and general manager, cell biology, for Thermo Fisher. “We’re proud to offer a deep portfolio of technologies that addresses the entire pluripotent stem cell research continuum to enable novel applications in drug discovery and human disease studies.” 

New product innovations at ISSCR this year include: 

• When used in combination, the new Lipofectamine 3000 and Epi5 Episomal iPSC Reprogramming Vector reagents demonstrate robust transfection and development of iPSCs and eliminate the need for electroporation, reduce cytotoxicity for more stable, physiologically relevant iPSCs; 

• The new PSC Cardiomyocyte Differentiation Kit is designed to deliver rapid differentiation of iPSCs to contracting cardiomyocytes in as few as eight days using a simple three-step process; 

• The new Molecular Probes Human Cardiomyocyte Immunocytochemistry and PSC Live Staining Kit is one of nine different characterization kits designed to deliver convenience with all the necessary reagents in a single box to enable superior imaging for fluorescence microscopy-based analysis of live or fixed cells; 

• To elevate stem cell differentiation, the new Thermo Scientific Nunclon Sphera non-adherent cell culture surface optimizes three-dimensional spheroid formation designed to allow researchers to grow cells in suspension with consistency and reproducibility; and 

• Also on display will include Gibco Essential 8 Medium for growing human iPSCs, updated analysis software for the TaqMan hPSC Scorecard Panel (qPCR-based stem cell characterization), Thermo Scientific Nalgene RapidFlow filtration designed to prevent cell culture contamination, Thermo Scientific cryopreservation consumables, and Fisher BioServices ultra cold-chain logistics for cellular therapeutics clinical trials and commercialization. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific Announces Winners of 2016 Winter Conference Awards in Plasma Spectrochemistry
Independent committee recognizes significant contributions in plasma spectrochemistry.
Wednesday, September 23, 2015
Thermo Fisher Scientific Receives IVDD CE Mark for LC-MS Products
Now available to clinical laboratories in Europe for general in vitro diagnostic use.
Friday, September 11, 2015
Thermo Launches Geneticon
Thermo Fisher Scientific launches GenetiCon, a virtual resource showcasing the real-life science behind superheroic powers and more.
Tuesday, July 07, 2015
Thermo Fisher Agrees to Buy Alfa Aesar for $403M
The company announced a definitive agreement to buy the research chemical manufacturer for $403 million.
Friday, June 26, 2015
Ebola Sequencing Data Released to Global Research Community Online
To curb further spread of Ebola in Sierra Leone, a team of scientists that is part of an international, multi-organizational effort has released their first dataset of the virus’ genetic structure online.
Wednesday, June 03, 2015
Thermo's NGS Platform Selected for Nationwide Clinical Research Program
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.
Monday, June 01, 2015
Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition
Thermo Fisher Scientific has acquired Advanced Scientifics, Inc., a global provider of single-use technologies for customized bioprocessing solutions, for $300 million in cash.
Friday, February 06, 2015
Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Scientific Announces Listing of the Ion PGM Dx System
Company has completed the listing with the U.S. FDA as class II medical device.
Saturday, September 20, 2014
Thermo Fisher, NRLs Team to Confirm Dioxins in Feed and Food
Thermo Fisher Scientific worked closely with national reference labs (NRLs) in the European Union to support the development of new regulation.
Monday, September 08, 2014
Thermo Completes Sale of Cole-Parmer to GTCR
Thermo Fisher Scientific Inc. announced that it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR LLC for approximately $480 million in cash.
Wednesday, August 20, 2014
Thermo Supports Distinguished Analytical Chemistry Seminar Series at NC State
An endowment established by the company provides opportunities to attend presentations by leading analytical chemistry authorities.
Tuesday, August 19, 2014
NSF International Expands Use of Thermo Scientific Watson LIMS
NSF International implements Thermo Scientific Watson LIMS to support bioanalytical testing for both clinical and non-clinical research studies at Bristol, CT laboratory.
Saturday, August 09, 2014
Thermo, NewLab Sign Forensic Sample Processing Distribution Agreement
Under the agreement, Thermo Fisher is the sole distributor and servicing agent of the CPA300™ and CPA200™ card processing instruments.
Friday, July 25, 2014
Thermo to Sell Cole-Parmer for $480M
Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.
Monday, July 21, 2014
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos